CAMAP: Artificial neural networks unveil the role of codon arrangement in modulating MHC-I peptides presentation.

Journal: PLoS computational biology
Published Date:

Abstract

MHC-I associated peptides (MAPs) play a central role in the elimination of virus-infected and neoplastic cells by CD8 T cells. However, accurately predicting the MAP repertoire remains difficult, because only a fraction of the transcriptome generates MAPs. In this study, we investigated whether codon arrangement (usage and placement) regulates MAP biogenesis. We developed an artificial neural network called Codon Arrangement MAP Predictor (CAMAP), predicting MAP presentation solely from mRNA sequences flanking the MAP-coding codons (MCCs), while excluding the MCC per se. CAMAP predictions were significantly more accurate when using original codon sequences than shuffled codon sequences which reflect amino acid usage. Furthermore, predictions were independent of mRNA expression and MAP binding affinity to MHC-I molecules and applied to several cell types and species. Combining MAP ligand scores, transcript expression level and CAMAP scores was particularly useful to increase MAP prediction accuracy. Using an in vitro assay, we showed that varying the synonymous codons in the regions flanking the MCCs (without changing the amino acid sequence) resulted in significant modulation of MAP presentation at the cell surface. Taken together, our results demonstrate the role of codon arrangement in the regulation of MAP presentation and support integration of both translational and post-translational events in predictive algorithms to ameliorate modeling of the immunopeptidome.

Authors

  • Tariq Daouda
    Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
  • Maude Dumont-Lagacé
    Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
  • Albert Feghaly
    Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
  • Yahya Benslimane
    Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
  • Rébecca Panes
    Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
  • Mathieu Courcelles
    Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
  • Mohamed Benhammadi
    Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
  • Lea Harrington
    Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
  • Pierre Thibault
    From the ‡Institute for Research in Immunology and Cancer, pierre.thibault@umontreal.ca md.tyers@umontreal.ca.
  • François Major
    Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
  • Yoshua Bengio
    Université de Montréal, Montréal QC H3T 1N8, Canada.
  • Étienne Gagnon
    Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
  • Sébastien Lemieux
    Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
  • Claude Perreault
    Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.